Nanobots Successfully Destroy Cancer Cells

In a new report from Nature, a team of scientists have just announced that their latest invention of autonomous nanobots can successfully be deployed within mice as a means of combating and curing cancer.

Using specially programmed DNA strands folded onto themselves, these nanobots seek out cancerous cells within a mouse and inject them with a drug that causes blood clots, cutting off a tumor’s supply of blood and causing it to die off before any harm can be done to the host.

The initial tests for these bots were carried out on mice injected with human breast cancer tissue samples. Within just two days of being injected intravenously with the DNA nanobots, the cancer cells had all begun to die off after the bots successfully located them and started treatment. Additionally, no other parts of the mices’ bodies were seen to have irregular clotting, meaning this treatment would carry little to no risk for patients.

Not only that, when this experiment was replicated with a species of miniature pig, the results turned out to be the same. As there were no signs of clotting in these pigs, it would suggest that even larger creatures would not face unexpected side effects from this cancer treatment as some have feared. The study authors say that they hope to be able to see the same results if they are ever cleared for testing on humans, wishing to implement these nanobots as a human cancer treatment one day.

Compared to other forms of cancer treatment like chemotherapy or invasive surgeries, it’s clear that this nanobot-focused strategy is the way of the future. While many more tests will need to be done before any trials could be conducted on human test subjects, the possibilities are no less impressive. Should these nanobots be approved for treatment strategies after that, they could completely change how we deal with cancer, greatly reducing the mortality rate and level of seriousness associated with the disease.

Leave a Reply

Your email address will not be published. Required fields are marked *